The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

Cryoablation and radiofrequency (RF) ablation can cause damage to non-targeted tissues, such as the pulmonary vein, esophagus and phenic nerve. As a result, PFA has emerged as an appealing alternative ...

Having two renowned physicians showcase the clinical benefits of the differentiated mechanism of action and device at this ... for pulmonary vein isolation, and 3D mapping and navigation with ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

The fully integrated platform is designed to enable the treatment of atrial fibrillation with a single device that combines ... 3D navigation and cardiac mapping. The approval of the Varipulse ...

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

“The remap results for the first 30 patients treated with the Nanosecond PFA 360° Cardiac Catheter demonstrate strong pulmonary vein isolation ... Catheter with 3D mapping and navigation ...

This is the idea that by being incredibly body literate and taking steps to understand the state of your health now, you can ...

China strengthens its dominance in rare earths with a new find in Yunnan, key to technology and defense, impacting global ...

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students ...

In Heart Failure, growth of 9.5% was driven by our market-leading portfolio of heart-assist devices, which offer treatment for chronic and temporary conditions. In Vascular, growth of 7% was led ...